Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review.
Ejaz CheemaPublished in: Journal of pharmaceutical policy and practice (2019)
The current evidence related to the potential association of CKD with PPI use remains inconclusive in establishing true causality. Further prospective studies including randomised controlled trials and cohort studies would be required to confirm the findings reported in this review and to draw any conclusions.